{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:30:04Z","timestamp":1792416604506,"version":"4.4.0"},"reference-count":44,"publisher":"Siapec Servizi Srl","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-n1518","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T15:06:36Z","timestamp":1763391996000},"page":"384-392","source":"Crossref","is-referenced-by-count":3,"title":["TFE3-rearranged and TFEB-altered renal cell carcinoma: from classification to real-life. Insights from a national Italian survey"],"prefix":"10.32074","volume":"117","author":[{"given":"Stefano","family":"Marletta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cali\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Nicol\u00f2","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Giovanni","family":"Bonadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Covelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Francesconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Liscia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Onnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Raspollini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steno","family":"Sentinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Valeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Martignoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21774","published-online":{"date-parts":[[2025,10]]},"reference":[{"key":"10.32074\/1591-951X-N1518_ref1","unstructured":"WHO Classification of Tumours Editorial Board, ed. WHO Classification of Tumours, Urinary and Male Genital Tumours. 5th ed. Lyon: IARC press; 2022."},{"key":"10.32074\/1591-951X-N1518_ref2","doi-asserted-by":"crossref","unstructured":"Cali\u00f2 A, Marletta S, Brunelli M, et al. WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist. Pathologica 2022;115:23\u201331. https:\/\/doi.org\/10.32074\/1591-951X-814.","DOI":"10.32074\/1591-951X-814"},{"key":"10.32074\/1591-951X-N1518_ref3","doi-asserted-by":"crossref","unstructured":"Cali\u00f2 A, Segala D, Munari E, et al. MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge. Cancers (Basel). 2019;11. https:\/\/doi.org\/10.3390\/cancers11081110.","DOI":"10.3390\/cancers11081110"},{"key":"10.32074\/1591-951X-N1518_ref4","unstructured":"Moch H, Humphrey PA, Ulbright TM, et al. WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th ed. Lyon: IARC press; 2016."},{"key":"10.32074\/1591-951X-N1518_ref5","doi-asserted-by":"crossref","unstructured":"Komai Y, Fujiwara M, Fujii Y, et al. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin. Cancer Res. 2009;15:1170\u20131176. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-1183.","DOI":"10.1158\/1078-0432.CCR-08-1183"},{"key":"10.32074\/1591-951X-N1518_ref6","doi-asserted-by":"crossref","unstructured":"Sukov WR, Hodge JC, Lohse CM, et al. TFE3 rearrangements in adult renal cell carcinoma: clinical and pathologic features with outcome in a large series of consecutively treated patients. Am. J. Surg. Pathol. 2012;36:663\u2013670. https:\/\/doi.org\/10.1097\/PAS.0b013e31824dd972.","DOI":"10.1097\/PAS.0b013e31824dd972"},{"key":"10.32074\/1591-951X-N1518_ref7","unstructured":"Associazione Italiana Oncologia Medica. I numeri del cancro in Italia.; 2024."},{"key":"10.32074\/1591-951X-N1518_ref8","doi-asserted-by":"crossref","unstructured":"Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am. J. Pathol. 2001;159:179\u2013192. https:\/\/doi.org\/10.1016\/S0002-9440(10)61684-7.","DOI":"10.1016\/S0002-9440(10)61684-7"},{"key":"10.32074\/1591-951X-N1518_ref9","doi-asserted-by":"crossref","unstructured":"Marletta S, Cali\u00f2 A, Pierconti F, et al. SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocation. Pathol. Res. Pract. 2025;270:155963. https:\/\/doi.org\/10.1016\/j.prp.2025.155963.","DOI":"10.1016\/j.prp.2025.155963"},{"key":"10.32074\/1591-951X-N1518_ref10","doi-asserted-by":"crossref","unstructured":"Kammerer-Jacquet S-F, Gandon C, Dugay F, et al. Comprehensive study of nine novel cases of TFEB-amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression. Histopathology 2022. https:\/\/doi.org\/10.1111\/his.14683.","DOI":"10.1111\/his.14683"},{"key":"10.32074\/1591-951X-N1518_ref11","doi-asserted-by":"crossref","unstructured":"Peckova K, Vanecek T, Martinek P, et al. Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature. Ann. Diagn. Pathol. 2014;18:351\u2013357. https:\/\/doi.org\/10.1016\/j.anndiagpath.2014.10.002.","DOI":"10.1016\/j.anndiagpath.2014.10.002"},{"key":"10.32074\/1591-951X-N1518_ref12","doi-asserted-by":"crossref","unstructured":"Smith NE, Illei PB, Allaf M, et al. t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases. Am. J. Surg. Pathol. 2014;38:604\u2013614. https:\/\/doi.org\/10.1097\/PAS.0000000000000203.","DOI":"10.1097\/PAS.0000000000000203"},{"key":"10.32074\/1591-951X-N1518_ref13","doi-asserted-by":"crossref","unstructured":"Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am. J. Surg. Pathol. 2002;26:1553\u20131566. https:\/\/doi.org\/10.1097\/00000478-200212000-00003.","DOI":"10.1097\/00000478-200212000-00003"},{"key":"10.32074\/1591-951X-N1518_ref14","doi-asserted-by":"crossref","unstructured":"Hayes M, Peckova K, Martinek P, et al. Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma. Virchows Arch. 2015;466:313\u2013322. https:\/\/doi.org\/10.1007\/s00428-014-1702-7.","DOI":"10.1007\/s00428-014-1702-7"},{"key":"10.32074\/1591-951X-N1518_ref15","doi-asserted-by":"crossref","unstructured":"Wang X-T, Xia Q-Y, Ye S-B, et al. RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations. Mod. Pathol. 2018;31:1346\u20131360. https:\/\/doi.org\/10.1038\/s41379-018-0051-5.","DOI":"10.1038\/s41379-018-0051-5"},{"key":"10.32074\/1591-951X-N1518_ref16","doi-asserted-by":"crossref","unstructured":"Song Y, Yin X, Xia Q, et al. Xp11 translocation renal cell carcinoma with morphological features mimicking multilocular cystic renal neoplasm of low malignant potential: a series of six cases with molecular analysis. J. Clin. Pathol. 2021;74:171\u2013176. https:\/\/doi.org\/10.1136\/jclinpath-2020-206681.","DOI":"10.1136\/jclinpath-2020-206681"},{"key":"10.32074\/1591-951X-N1518_ref17","doi-asserted-by":"crossref","unstructured":"Argani P. MiT family translocation renal cell carcinoma. Semin. Diagn. Pathol. 2015;32:103\u2013113. https:\/\/doi.org\/10.1053\/j.semdp.2015.02.003.","DOI":"10.1053\/j.semdp.2015.02.003"},{"key":"10.32074\/1591-951X-N1518_ref18","doi-asserted-by":"crossref","unstructured":"Cali\u00f2 A, Brunelli M, Segala D, et al. T(6;11) renal cell carcinoma: A study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa\/epithelioid angiomyolipoma. Mod. Pathol. 2018;31:474\u2013487. https:\/\/doi.org\/10.1038\/modpathol.2017.144.","DOI":"10.1038\/modpathol.2017.144"},{"key":"10.32074\/1591-951X-N1518_ref19","doi-asserted-by":"crossref","unstructured":"Cali\u00f2 A, Harada S, Brunelli M, et al. TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1. Mod. Pathol. 2021;34:842\u2013850. https:\/\/doi.org\/10.1038\/s41379-020-00713-6.","DOI":"10.1038\/s41379-020-00713-6"},{"key":"10.32074\/1591-951X-N1518_ref20","doi-asserted-by":"crossref","unstructured":"Cali\u00f2 A, Marletta S, Stefanizzi L, et al. Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma. Mod. Pathol. 2024;37:100561. https:\/\/doi.org\/10.1016\/j.modpat.2024.100561.","DOI":"10.1016\/j.modpat.2024.100561"},{"key":"10.32074\/1591-951X-N1518_ref21","doi-asserted-by":"crossref","unstructured":"Xia Q-Y, Wang X-T, Fang R, et al. Clinicopathologic and Molecular Analysis of the TFEB Fusion Variant Reveals New Members of TFEB Translocation Renal Cell Carcinomas (RCCs): Expanding the Genomic Spectrum. Am. J. Surg. Pathol. 2020;44:477\u2013489. https:\/\/doi.org\/10.1097\/PAS.0000000000001408.","DOI":"10.1097\/PAS.0000000000001408"},{"key":"10.32074\/1591-951X-N1518_ref22","doi-asserted-by":"crossref","unstructured":"Argani P, Olgac S, Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am. J. Surg. Pathol. 2007;31:1149\u20131160. https:\/\/doi.org\/10.1097\/PAS.0b013e318031ffff.","DOI":"10.1097\/PAS.0b013e318031ffff"},{"key":"10.32074\/1591-951X-N1518_ref23","doi-asserted-by":"crossref","unstructured":"Skala SL, Xiao H, Udager AM, et al. Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays. Mod. Pathol. 2018;31:179\u2013197. https:\/\/doi.org\/10.1038\/modpathol.2017.99.","DOI":"10.1038\/modpathol.2017.99"},{"key":"10.32074\/1591-951X-N1518_ref24","doi-asserted-by":"crossref","unstructured":"Akgul M, Williamson SR, Ertoy D, et al. Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey. J. Clin. Pathol. 2021;74:291\u2013299. https:\/\/doi.org\/10.1136\/jclinpath-2020-207372.","DOI":"10.1136\/jclinpath-2020-207372"},{"key":"10.32074\/1591-951X-N1518_ref25","doi-asserted-by":"crossref","unstructured":"Cali\u00f2 A, Brunelli M, Segala D, et al. Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets. Pathology 2020;52:297\u2013309. https:\/\/doi.org\/10.1016\/j.pathol.2019.11.006.","DOI":"10.1016\/j.pathol.2019.11.006"},{"key":"10.32074\/1591-951X-N1518_ref26","doi-asserted-by":"crossref","unstructured":"Cali\u00f2 A, Marletta S, Brunelli M, et al. TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms. Virchows Arch. 2022. https:\/\/doi.org\/10.1007\/s00428-022-03380-x.","DOI":"10.1007\/s00428-022-03380-x"},{"key":"10.32074\/1591-951X-N1518_ref27","doi-asserted-by":"crossref","unstructured":"Cali\u00f2 A, Brunelli M, Gobbo S, et al. Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors. Cancers (Basel). 2021;13. https:\/\/doi.org\/10.3390\/cancers13102441.","DOI":"10.3390\/cancers13102441"},{"key":"10.32074\/1591-951X-N1518_ref28","doi-asserted-by":"crossref","unstructured":"Cali\u00f2 A, Marletta S, Brunelli M, et al. TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum. Cancers (Basel). 2024;16. https:\/\/doi.org\/10.3390\/cancers16193396.","DOI":"10.3390\/cancers16193396"},{"key":"10.32074\/1591-951X-N1518_ref29","doi-asserted-by":"crossref","unstructured":"Martignoni G, Bonetti F, Chilosi M, et al. Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney. Mod. Pathol. 2012;25:100\u2013111. https:\/\/doi.org\/10.1038\/modpathol.2011.136.","DOI":"10.1038\/modpathol.2011.136"},{"key":"10.32074\/1591-951X-N1518_ref30","doi-asserted-by":"crossref","unstructured":"Martignoni G, Pea M, Gobbo S, et al. Cathepsin-K immunoreactivity distinguishes MiTF\/TFE family renal translocation carcinomas from other renal carcinomas. Mod. Pathol. 2009;22:1016\u20131022. https:\/\/doi.org\/10.1038\/modpathol.2009.58.","DOI":"10.1038\/modpathol.2009.58"},{"key":"10.32074\/1591-951X-N1518_ref31","doi-asserted-by":"crossref","unstructured":"Martignoni G, Gobbo S, Camparo P, et al. Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions. Mod. Pathol. 2011;24:1313\u20131319. https:\/\/doi.org\/10.1038\/modpathol.2011.93.","DOI":"10.1038\/modpathol.2011.93"},{"key":"10.32074\/1591-951X-N1518_ref32","doi-asserted-by":"crossref","unstructured":"Iakymenko OA, Delma KS, Jorda M, et al. Cathepsin K (Clone EPR19992) Demonstrates Uniformly Positive Immunoreactivity in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Distal Tubules. Int. J. Surg. Pathol. 2021;29:600\u2013605. https:\/\/doi.org\/10.1177\/1066896921991588.","DOI":"10.1177\/1066896921991588"},{"key":"10.32074\/1591-951X-N1518_ref33","doi-asserted-by":"crossref","unstructured":"Fioramonti M, Santini D, Iuliani M, et al. Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. Oncotarget 2017;8:20113\u201320121. https:\/\/doi.org\/10.18632\/oncotarget.15390.","DOI":"10.18632\/oncotarget.15390"},{"key":"10.32074\/1591-951X-N1518_ref34","doi-asserted-by":"crossref","unstructured":"Rizzo M, Pezzicoli G, Santoni M, et al. MiT translocation renal cell carcinoma: A review of the literature from molecular characterization to clinical management. Biochim. Biophys. Acta. Rev. Cancer 2022;1877:188823. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188823.","DOI":"10.1016\/j.bbcan.2022.188823"},{"key":"10.32074\/1591-951X-N1518_ref35","doi-asserted-by":"crossref","unstructured":"Lin Y, Shi Q, Yang G, et al. A small-molecule drug inhibits autophagy gene expression through the central regulator TFEB. Proc. Natl. Acad. Sci. U. S. A. 2023;120:e2213670120. https:\/\/doi.org\/10.1073\/pnas.2213670120.","DOI":"10.1073\/pnas.2213670120"},{"key":"10.32074\/1591-951X-N1518_ref36","doi-asserted-by":"crossref","unstructured":"Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am. J. Surg. Pathol. 2003;27:750\u2013761. https:\/\/doi.org\/10.1097\/00000478-200306000-00005.","DOI":"10.1097\/00000478-200306000-00005"},{"key":"10.32074\/1591-951X-N1518_ref37","doi-asserted-by":"crossref","unstructured":"Sharain RF, Gown AM, Greipp PT, et al. Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study. Hum. Pathol. 2019;87:65\u201374. https:\/\/doi.org\/10.1016\/j.humpath.2019.02.008.","DOI":"10.1016\/j.humpath.2019.02.008"},{"key":"10.32074\/1591-951X-N1518_ref38","doi-asserted-by":"crossref","unstructured":"Argani P, Zhang L, Reuter VE, et al. RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH. Am. J. Surg. Pathol. 2017;41:655\u2013662. https:\/\/doi.org\/10.1097\/PAS.0000000000000835.","DOI":"10.1097\/PAS.0000000000000835"},{"key":"10.32074\/1591-951X-N1518_ref39","doi-asserted-by":"crossref","unstructured":"Xia Q-Y, Wang Z, Chen N, et al. Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement. Mod. Pathol. 2017;30:416\u2013426. https:\/\/doi.org\/10.1038\/modpathol.2016.204.","DOI":"10.1038\/modpathol.2016.204"},{"key":"10.32074\/1591-951X-N1518_ref40","doi-asserted-by":"crossref","unstructured":"Harada S, Cali\u00f2 A, Janowski KM, et al. Diagnostic utility of one-stop fusion gene panel to detect TFE3\/TFEB gene rearrangement and amplification in renal cell carcinomas. Mod. Pathol. 2021;34:2055\u20132063. https:\/\/doi.org\/10.1038\/s41379-021-00858-y.","DOI":"10.1038\/s41379-021-00858-y"},{"key":"10.32074\/1591-951X-N1518_ref41","doi-asserted-by":"crossref","unstructured":"Tretiakova MS, Wang W, Wu Y, et al. Gene fusion analysis in renal cell carcinoma by FusionPlex RNA-sequencing and correlations of molecular findings with clinicopathological features. Genes. Chromosomes Cancer 2020;59:40\u201349. https:\/\/doi.org\/10.1002\/gcc.22798.","DOI":"10.1002\/gcc.22798"},{"key":"10.32074\/1591-951X-N1518_ref42","doi-asserted-by":"crossref","unstructured":"Tretiakova MS. Chameleon TFE3-translocation RCC and How Gene Partners Can Change Morphology: Accurate Diagnosis Using Contemporary Modalities. Adv. Anat. Pathol. 2022;29:131\u2013140. https:\/\/doi.org\/10.1097\/PAP.0000000000000332.","DOI":"10.1097\/PAP.0000000000000332"},{"key":"10.32074\/1591-951X-N1518_ref43","doi-asserted-by":"crossref","unstructured":"Yan M, Wang R, Guan W, et al. A clinicopathological and molecular series of five TFEB-altered renal cell carcinoma (RCC) cases: highlighting an aggressive subset of TFEB-rearranged RCC concomitant with TFEB amplification\/gene copy number gains. Virchows Arch. 2024;485:1041\u20131051. https:\/\/doi.org\/10.1007\/s00428-024-03968-5.","DOI":"10.1007\/s00428-024-03968-5"},{"key":"10.32074\/1591-951X-N1518_ref44","doi-asserted-by":"crossref","unstructured":"Zhang M, Xian J, Tang J, et al. Clinicopathologic and Molecular Study of TFEB-altered Renal Cell Carcinomas: Tumors With Frequent PDL1 Expression. Am. J. Surg. Pathol. 2025. https:\/\/doi.org\/10.1097\/PAS.0000000000002458.","DOI":"10.1097\/PAS.0000000000002458"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/1518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T15:07:18Z","timestamp":1763392038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pathologica.it\/article\/view\/1518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,9]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-n1518","relation":{},"ISSN":["1591-951X"],"issn-type":[{"value":"1591-951X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"article-number":"9"}}